drugset / Trial / NCT01434745
SLOS: The Effect of Simvastatin in Patients Receiving Cholesterol Supplementation
Terminated
1 enrolled
Oregon Health and Science University
National Heart, Lung, and Blood Institute (NHLBI) · collab
RandomizedCrossoverSingle-blindTreatment
Summary
The purpose of this study is to determine if simvastatin improves development and behavior in patients with Smith Lemli-Opitz syndrome (SLOS) receiving dietary cholesterol supplementation.
Timeline
- Start
- 2011-09
- Primary completion
- 2014-10
- Completion
- 2014-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Simvastatin | Small molecule | 0.5 mg/kg | — |